View graph of relations


    Professor Manuel Salto-Tellez (MD-LMS, FRCPath, FRCPI) is the Chair of Molecular Pathology at Queen’s University Belfast, Clinical Consultant Pathologist at the Belfast Health and Social Care Trust and Deputy Director of the Centre for Cancer Research and Cell Biology.


    August 1991

    Degree (LMS, MD equivalent): Título de Licenciado en Medicina y Cirugía,

    October 1998


    February 2006


    December 2013

    FRCPI – 48435                        

    December 2001

    Mol Path Fellowship:  

    April 1999

    Certificate of Completion of Specialist Training (UK)             


    General Medical Council Registration Number (UK): 3624504


    Singapore Medical Council Registration Number: 08697E


    Member of the Royal College of Pathologists: 070761X/ME


    EDUCATION - Medical Schools (in the context of the ERASMUS Programme)


    University of Oviedo, Spain;


    R-W Technischen Hochschule Aachen, Germany;


    The Royal University of Leiden, The Netherlands.


    PREVIOUS POSTS (in brief chronological order)

    1992 to 2002

    Trainee in Pathology at the University of Edinburgh (Royal Infirmary) and the Northwick Park & St. Mark’s Hospitals in London; Fellow in Diagnostic Molecular Pathology at UPENN (USA)

    1999 - 2011:

    Assistant and Associate Professor, National University of Singapore (NUS). From 2004 - Sr. Research Scientist at the NUS Cancer Science Institute

    1999 - 2011:

    Consultant and Senior Consultant, Department of Pathology, National University Hospital (NUH), Singapore. Director, Diagnostic Molecular Oncology Centre, NUH

    2007 - 2010:

    Assist. Dean & Vice-dean for Research, NUS. Head of Clinical Science Research at the National University Health System (NUHS)

    2011 to 2014:

    Visiting Professor, Department of Pathology & Cancer Science Institute, NUS 

    March 2011 to date:

    Chair and Professor of Molecular Pathology, Centre for Cancer Research and Cell Biology (CCRCB); School of Medicine, Dentistry and Biomedical Sciences (SMDBS), Queen’s University Belfast (QUB), United Kingdom

    March 2011 to date:

    Clinical Consultant, Belfast Health and Social Care Trust, UK

    July 2012 to date:

    Deputy Director, CCRCB; SMDBS, QUB, UK

    May 2014 to date:

    Associate member of the Cancer Science Institute, NUS

    July 2016 to date:

    Clinical Director, Molecular Diagnostics, Northern Ireland remit



    August 2011-14:

    Member of the Interspecialty Committee on Molecular Pathology in the Royal College of Pathologists of Great Britain and Ireland

    Since March 2012:

    Member of the Colorectal Group of the National Cancer Research Institute

    Novem 2012-17:

    Member of the Molecular Pathology Committee of the Association of Clinical Pathology

    March 2013-16:

    Member of the Ex. Group of the Confederation of Cancer Biobanks, National Cancer Research Institute

    Since June 2013:

    Member of the Cancer Research UK Biomarker Expert Review Panel.

    Since April 2014:

    ECMC Cellular and Molecular Pathology (CM-Path) Network Group

    Since Decem 2014:

    Member of the UKNEQAS Committee for DNA Quality

    Since Novem 2014:

    Member of the Molecular Pathology Committee of Genomics England

    Since Decem 2014:

    Member of the Genomics England GCIPs on CRC and data interpretation

    Since August 2015:

    Member of the Wales Cancer Research Centre’s External Advisory Board

    Since July 2016:

    Member of the Main Committee of the Pathological Society of GB & Ireland

    Since 2016:

    Member of the Cancer Research UK New Agents Committee

    July 2016:

    Member of the Independent Selection Panel for applications for NIHR funding and designation for Clinical Research Facilities for early translational research (Department of Health)

    January 2017

    Member of the NIHR Senior Investigators Appointment Panel (Department of Health)


    RESEARCH GRANTS (selection) – From a total lifetime to date of £7.9M

    In Singapore (selection, from a total of S$5.17M - 1£ = 2.2 Singapore $)

    Singapore Cancer Syndicate          April 2004 – March 2005: S$275,000

    April 2005 – March 2008: S$1,890,000

    April 2006 – March 2009: S$1,200,000

    July 2008 – July 2011: S$1,005,000


    In Queen’s University Belfast (from £4.9M of active funding, selection)          Project Title

    R1089CNR - Medical Research Council - £163,015

    Central Importance of CXCL8 to Inflammation - Promoted Prostate Cancer Progression

    R2116CNR - Prostate Cancer UK - £273,017

    Movember Centre of Excellence

    R3511CNR - Invest NI - £359,272

    Establishment of an Intergrated Almac-QUB Drug Discovery Unit at QUB

    CRUK - £3,900,000 £

    CR-UK Accelerator Award

    Pending final confirmation:

    Centre of Excellence in Mol Pathology £10,000,000



    Awards (selection)

    November 1990,

    Erasmus Prize of the European Community;


    Courage Star by the Courage Fund. This was in recognition to the work developed during the Severe Acute Respiratory Syndrome (SARS) crisis that affected (primarily) the South-east of Asia in 2003;


    World Scientists Forum International Award in the field of Onco-Cytology by the International Research Promotion Council (IRPC);

    28-29 March 2008

    Silver frame in recognition to research in the area of gastrointestinal diseases, presented at the 13th Annual Helenic Helicobacter Pylori Congress, Athens

    March 10-11 2010

    Keynote Speaker at the 6th Annual Tucson Symposium: Targeted Therapeutics: Leading the Global Paradigm Shift for Pathology, Arizona

    7-10 October 2011

    Keynote  Speaker at the 41st annual Scientific Meeting of the Australian Society of Cytology. Molecular Biology for the Cytologists, Perth

    14 February 2014

    Key note speaker at the 32nd Annual Symposium of the Faculty of Pathology of the Royal College of Physicians of Ireland. Integrated Molecular Tissue Pathology.

    14-15 March 2016

    Leading member of the Advisory Panel to the Division of Cancer Epidemiology and Genomics on Molecular Pathology, NCI/NIH,  (Drs. Stephen Chanok and Montserrat Garcia-Closas)

    March-April 2016

    Reviewer to the Molecular Pathology Programme at the Ontario Institute of Cancer Research, Canada, (Dr. Thomas J Hudson, President and Scientific Director)


    Invitations to meetings (strict selection, only since 2010)


    24-25 April 2010 

    Speaker at the “2010 AstraZeneca Asia Pacific Oncology Summit” - EGFR Mutation Testing, in Taipei, Taiwan.

    16-20 May 2010

    Invited speaker at the 17th International Congress of Cytology (International Academy of Cytology) to deliver the lecture “Molecular Cytopathology and Personalised Medicine” at the International Conference Centre in Edinburgh, UK, – ACTA CYTOLOGICA  54,3:385-85 2010

    June 9-10 2010 

    Invited Speaker at the 3rd InterAcademy Medical Panel (IAMP) and General Assembly meeting - “Molecular Diagnostics in Cancer and Implications for the Developing World”, in Kuala Lumpur, Malaysia,

    4-5 Septem 2010

    Invited Speaker and Guest of Honour at the 2010 Annual Meeting of the Sri Lankan Society of Pathology to deliver several lectures, workshops and speeches, at Kandy, Sri Lanka,

    October 1-3 2010

    Invited speaker (Plenary Speaker, inaugural session) at the 2010 Annual Scientific Congress of the Malaysian Oncological Society - Role of Pathologist in Personalized Cancer Treatment, at Kota Bharu, Kelantan, Malaysia,

    23 October 2010

    Invited Speaker at the 8th Meeting of the Association of Directors of Pathology of China - Molecular Pathology, Targeted Therapeutics and the Future of Pathology, Shanghai Everbright Convention & Exhibition Center, China,

    Novem 9–11 2010

    Invited speaker at the International Conference in Laboratory Medicine at the Sultan Qaboos University, Muscat (Oman): “Molecular Pathology – A hospital based platform for Translational Research”


    May 9-10 2011

    Invited Speaker by the The Western Australian Clinical Oncology Group - “The Future of Personalized Medicine from a Diagnostic and Therapeutic Perspective”, “Histopathology, Molecular Diagnostics and Therapeutic Pathology - challenges and opportunities” and “Tissue-based Translational Research”, Perth (Australia)

    Septem 7-8 2011

    2nd Meeting of the Society for Translational Oncology / 3rd CCRCB International Cancer Symposium: EGFR mutation analysis: a paradigm for the future of therapeutic pathology and personalized medicine. Belfast 


    8-10 March 2012

    Invited Speaker at Coloproctology 2012, 10th annual meeting of the Malaysian Society of Colorectal Surgeons - “Histopathological assessment of rectal cancer resection specimens”, “Introduction to biopsy interpretation” and  “Molecular diagnostics of GIT pathology”, as well as the workshop “Colorectal Pathology”, in Kuching, Sarawak

    18 April 2012

    Invited speaker at the session - The Importance of Molecular Testing in Non-Small Cell Lung Cancer: Practical Advice for Clinicians 3rd European Lung Cancer Conference (ELCC) Geneva, Switzerland - “How should EGFR mutation status be evaluated?”

    May 23 2012

    Invited Speaker at the Marsden Annual Cancer Meeting, London - Molecular Pathology: Tissue is the issue

    8-12 Septem 2012

    Invited Speaker at the 24th European Congress of Pathology (Prague) -Predictive biomarkers in NSCLC in the pre­sent and the future; challenges and opportu­nities of a changing landscape

    30-31 Octob 2012

    Invited speaker at the 50th Anniversary Symposium on Molecular Pathology Symposium organized by the Royal College of Pathologist s of Great Britain and Ireland - Integrating genetics & histopathology, London

    11December 2012

    Invited Teaching Faculty at the first Molecular Pathology and Diagnosis of Cancer course (9-14 December 2012), organized by the Welcome Trust / Sanger Institute - “Tissue Molecular Diagnostics” and every year onwards


    20 April 2013

    Lecture “Era of Molecular Targeted Therapy for Lung Cancer: The Role of Pathology” at the Expert Practice in Lung Cancer Annual Meeting in Paris, France

    22 APRIL 2013

    Lecture “Aspectos Moleculares del cáncer gástrico. Avances en la clasificación del cáncer gástrico” at the FÓRMULA II EN CÁNCER GÁSTRICO meeting in Madrid, Spain

    26-30 May 2013

    Chairperson of the Symposium “ECHOENDOSCOPIC FNAC. Toward a more personalized medicine” and lecture “Introduction: cytology and lung cancer – a new paradigm?”, at the 18th International Congress of Cytology, Paris (France)

    2 September 2013

    Co-chairmanship of the session “Cytology and molecular testing: What is effective?” and lecture “Personalised Medicine and Molecular Cytopathology: a Critical Appraisal ” - 25th European Congress of Pathology in Lisbon (Portugal)


    Lecture: Molecular stratification of oesophago-gastric cancer. 2nd Translational Research Meeting of the EORTC GI-Group. University Hospital Carl Gustav Carus, Dresden, Germany.

    November 2013

    Lecture: What funders are looking for in a project involving tissue. Symposium by the Confederation of Cancer Biobanks, annual NCRI, Liverpool


    6 February 2014

    Facultade de Medicina da Universidade de São Paulo: The Northern Ireland Molecular Pathology Laboratory – New insights in Hepatocellular Carcinoma and Clinical Sequencing in Molecular Diagnostics. São Paulo, Brazil

    26-28 August 2014

    Invited speaker at the International Congress of Pathology and Laboratory Medicine (ICPaLM), in Kuala Lumpur, Malaysia, to deliver several lectures

    28 Septemb 2014

    Invited Speaker: European Society of Medical Oncology satellite symposium on “Understanding the Multidisciplinary Focus for Improving Gastric Cancer Care”, to lecture on The Role of Pathology in Gastric Cancer Care, Madrid (Spain) .


    23 February 2015

    Invited speaker to the Clínica Universitaria de Navarra: “Morpho-molecular Pathology: an Integrated Model for Diagnosis and Science”, Pamplona,

    16-17 April 2015

    Invited speaker at the Spanish Multidisciplinary Group for the Study of Cancer of the Digestive System (international meeting) to lecture: Advances in molecular classification of gastric cancer. Valencia, Spain

    24 June 2015

    Invited speaker: 8th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, to lecture “Training in Pathology – The Belfast Model”’, Dublin

    6-8 of August 2015

    Invited Speaker at the “II International Symposium on Personalized Medicine”, the Albert Einstein Research and Education Institute - “Next Generation Sequencing and Oncology“. São Paulo, (Brazil)



    27 June 2016

    Invited Speaker at the Universitätsspital Basel to deliver the lecture: “Future perspectives in Molecular Pathology – Changing Pathology Practice, Basel Switzerland

    4 October 2016

    Keynote Lecture at the 40th European Congress of Cytology - More than a decade of Molecular Diagnostic Cytopathology : How do we Practice it, how do we Teach it?, Liverpool (UK)

    21 October 2016

    Invited Lecture at the The Gathering Around Cancer, Croke Park - Microsatellite Instability, broad genomic testing and tumour microenvironment in colorectal cancer: Practical aspects in Pathology practice and clinical relevance. Dublin. Ireland

    17 November 2016

    Keynote Lecture at the Annual Meeting of the International Academy of Pathology - Finnish Division – “Digital workflows in molecular pathology”, Helsinki (Finland)



    2 February 2017

    Expert speaker at the Arab Health Congress, Dubai International Convention and Exhibition Centre., Dubai, UAE – Session “Leaders in Healthcare- Innovation in healthcare automation and technology”, talk - “Digital pathology workflows to deliver personalised medicine”

    13 March 2017

    Invited Lecture: Introduction to Molecular Pathology – what do we mean, what do you need to know, and why?  British Division of the International Academy of Pathology Molecular Pathology Study Day 

    31 March 2017

    Invited speaker - ‘‘Integrated Molecular Pathology and Translational Medicine’’, at the official launch of the Trinity Translational Medicine Institute – Trinity College Dublin


    June 2017

    Organizer – Biannual combines PathSoc/BDIAP meeting, Belfast The Waterfront

    November 2017

    Invited International Keynote speaker – Natinal Congress of Anantomic Pathology in Chile – Puerto Montt

    Frequent Journals

    • Histopathology

      ISSNs: 0309-0167

      Additional searchable ISSN (Electronic): 1365-2559


      Scopus rating (2018): CiteScore 2.67 SJR 1.245 SNIP 1.201


    • Journal of Clinical Pathology

      ISSNs: 0021-9746, 1472-4146

      Additional searchable ISSN (Electronic): 1472-4146

      BMJ Publishing Group

      Scopus rating (2018): CiteScore 2.1 SJR 1.085 SNIP 0.97


    • Oncotarget

      ISSNs: 1949-2553

      Impact Journals

      Scopus rating (2018): SJR 1.575 SNIP 0.904


    • British Journal of Cancer

      ISSNs: 0007-0920, 1532-1827

      Additional searchable ISSN (Electronic): 1532-1827

      Nature Publishing Group

      Scopus rating (2018): CiteScore 5.52 SJR 2.848 SNIP 1.654


    • Gastroenterology

      ISSNs: 0016-5085

      Additional searchable ISSN (Electronic): 1528-0012

      W.B. Saunders Ltd

      Scopus rating (2018): CiteScore 7.07 SJR 7.384 SNIP 3.884


    View all »

    ID: 57883